Literature DB >> 17019598

Increased insulin secretory capacity but decreased insulin sensitivity after correction of iron overload by phlebotomy in hereditary haemochromatosis.

D Abraham1, J Rogers, P Gault, J P Kushner, D A McClain.   

Abstract

AIMS/HYPOTHESIS: We recently demonstrated that humans with hereditary haemochromatosis have decreased insulin secretory capacity with a compensatory increase in insulin sensitivity. We therefore determined how these measures change after correction of tissue iron overload. SUBJECTS AND METHODS: Five non-diabetic subjects who had been studied previously at the time of initial diagnosis by means of the OGTT and frequently sampled intravenous glucose tolerance tests (FSIVGTT) underwent phlebotomy to normalise their serum ferritin. After normalisation of ferritin they were studied again (33+/-4 months after the initial studies) by OGTT and FSIVGTT.
RESULTS: Normalisation of tissue iron stores resulted in an average 1.8-fold increase in the integrated area under the insulin curve during OGTT (p<0.0001), but no significant change in the area under the glucose curve (10% decrease, p=0.32). After phlebotomy, there was a 2.2-fold increase in insulin secretory capacity as determined by FSIVGTT (acute insulin response to glucose [AIRg], p<0.02) but a concomitant 70% fall in insulin sensitivity (Si, p<0.05). The disposition index (AIRgxSi) was unchanged (5% increase, p=0.90). BMI and fasting glucose were unchanged. At the time of diagnosis of haemochromatosis, four of the subjects had IGT. After normalisation of ferritin, two achieved NGT and two remained with IGT, despite 2.5- and 3.7-fold increases in insulin secretory capacity. CONCLUSIONS/
INTERPRETATION: Insulin secretory capacity improves after normalisation of iron stores in subjects with hereditary haemochromatosis. Glucose tolerance status improves incompletely because of decreased insulin sensitivity after phlebotomy. We conclude that tissue iron levels are an important determinant of insulin secretion and insulin action.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17019598     DOI: 10.1007/s00125-006-0445-7

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  27 in total

1.  Clinical aspects of diabetes secondary to idiopathic haemochromatosis in French-speaking Belgium.

Authors:  M Buysschaert; I Paris; P Selvais; M P Hermans
Journal:  Diabetes Metab       Date:  1997-09       Impact factor: 6.041

Review 2.  Glucose toxicity.

Authors:  L Rossetti; A Giaccari; R A DeFronzo
Journal:  Diabetes Care       Date:  1990-06       Impact factor: 19.112

3.  Chronic hepcidin induction causes hyposideremia and alters the pattern of cellular iron accumulation in hemochromatotic mice.

Authors:  Lydie Viatte; Gaël Nicolas; Dan-Qing Lou; Myriam Bennoun; Jeanne-Claire Lesbordes-Brion; François Canonne-Hergaux; Kai Schönig; Hermann Bujard; Axel Kahn; Nancy C Andrews; Sophie Vaulont
Journal:  Blood       Date:  2005-12-08       Impact factor: 22.113

4.  Dietary factors associated with the risk of high iron stores in the elderly Framingham Heart Study cohort.

Authors:  Diana J Fleming; Katherine L Tucker; Paul F Jacques; Gerard E Dallal; Peter W F Wilson; Richard J Wood
Journal:  Am J Clin Nutr       Date:  2002-12       Impact factor: 7.045

5.  Factors affecting glucose tolerance in hereditary hemochromatosis.

Authors:  I M Hramiak; D T Finegood; P C Adams
Journal:  Clin Invest Med       Date:  1997-04       Impact factor: 0.825

6.  Method of insulin administration has no effect on insulin sensitivity estimates from the insulin-modified minimal model protocol.

Authors:  M F Saad; G M Steil; M Riad-Gabriel; A Khan; A Sharma; R Boyadjian; S D Jinagouda; R N Bergman
Journal:  Diabetes       Date:  1997-12       Impact factor: 9.461

7.  Mechanisms of insulin resistance in experimental hyperinsulinemic dogs.

Authors:  P D Miles; S Li; M Hart; O Romeo; J Cheng; A Cohen; K Raafat; A R Moossa; J M Olefsky
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

8.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors:  K G Alberti; P Z Zimmet
Journal:  Diabet Med       Date:  1998-07       Impact factor: 4.359

9.  Insulin-mediated and glucose-mediated glucose uptake following hemipancreatectomy in healthy human donors.

Authors:  E R Seaquist; K Pyzdrowski; A Moran; A U Teuscher; R P Robertson
Journal:  Diabetologia       Date:  1994-10       Impact factor: 10.122

10.  Hepcidin is decreased in TFR2 hemochromatosis.

Authors:  Elizabeta Nemeth; Antonella Roetto; Giovanni Garozzo; Tomas Ganz; Clara Camaschella
Journal:  Blood       Date:  2004-10-14       Impact factor: 22.113

View more
  17 in total

Review 1.  Diabetes and hemochromatosis.

Authors:  T Creighton Mitchell; Donald A McClain
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

Review 2.  Dysregulation of iron and copper homeostasis in nonalcoholic fatty liver.

Authors:  Elmar Aigner; Günter Weiss; Christian Datz
Journal:  World J Hepatol       Date:  2015-02-27

3.  Dietary iron restriction or iron chelation protects from diabetes and loss of beta-cell function in the obese (ob/ob lep-/-) mouse.

Authors:  Robert C Cooksey; Deborah Jones; Scott Gabrielsen; Jingyu Huang; Judith A Simcox; Bai Luo; Yudi Soesanto; Hugh Rienhoff; E Dale Abel; Donald A McClain
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-03-30       Impact factor: 4.310

4.  Hepcidin, soluble transferrin receptor and IL-6 levels in obese children and adolescents with and without type 2 diabetes mellitus/impaired glucose tolerance and their association with obstructive sleep apnea.

Authors:  S Shalitin; V Deutsch; R Tauman
Journal:  J Endocrinol Invest       Date:  2018-01-05       Impact factor: 4.256

Review 5.  Iron and diabetes risk.

Authors:  Judith A Simcox; Donald A McClain
Journal:  Cell Metab       Date:  2013-03-05       Impact factor: 27.287

Review 6.  Beta Cell Function and the Nutritional State: Dietary Factors that Influence Insulin Secretion.

Authors:  William T Moore; Suzanne M Bowser; Dane W Fausnacht; Linda L Staley; Kyung-Shin Suh; Dongmin Liu
Journal:  Curr Diab Rep       Date:  2015-10       Impact factor: 4.810

7.  Iron overload inhibits late stage autophagic flux leading to insulin resistance.

Authors:  James Won Suk Jahng; Reham Musaibeh Alsaadi; Rengasamy Palanivel; Erfei Song; Victoria Emily Barbosa Hipolito; Hye Kyoung Sung; Roberto Jorge Botelho; Ryan Charles Russell; Gary Sweeney
Journal:  EMBO Rep       Date:  2019-08-23       Impact factor: 8.807

8.  Adipocyte iron regulates adiponectin and insulin sensitivity.

Authors:  J Scott Gabrielsen; Yan Gao; Judith A Simcox; Jingyu Huang; David Thorup; Deborah Jones; Robert C Cooksey; David Gabrielsen; Ted D Adams; Steven C Hunt; Paul N Hopkins; William T Cefalu; Donald A McClain
Journal:  J Clin Invest       Date:  2012-09-10       Impact factor: 14.808

Review 9.  Hereditary hemochromatosis and diabetes mellitus: implications for clinical practice.

Authors:  Kristina M Utzschneider; Kris V Kowdley
Journal:  Nat Rev Endocrinol       Date:  2010-01       Impact factor: 43.330

10.  Dietary iron intake in the first 4 months of infancy and the development of type 1 diabetes: a pilot study.

Authors:  Ambika P Ashraf; Nancy B Eason; Edmond K Kabagambe; Josna Haritha; Sreelatha Meleth; Kenneth L McCormick
Journal:  Diabetol Metab Syndr       Date:  2010-09-20       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.